| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.925 | 77.764 | 169.421 | 60.198 | 148.360 | 248.346 | 179.727 | 182.033 | 261.311 | 168.031 |
| Total Income - EUR | 29.922 | 79.554 | 169.553 | 61.793 | 150.621 | 271.563 | 182.348 | 182.643 | 268.111 | 173.152 |
| Total Expenses - EUR | 55.005 | 58.723 | 115.437 | 60.515 | 108.188 | 129.946 | 93.456 | 75.889 | 144.191 | 126.832 |
| Gross Profit/Loss - EUR | -25.084 | 20.831 | 54.116 | 1.278 | 42.434 | 141.617 | 88.892 | 106.754 | 123.920 | 46.320 |
| Net Profit/Loss - EUR | -25.937 | 20.053 | 52.422 | 673 | 41.198 | 139.835 | 86.960 | 105.028 | 121.302 | 41.101 |
| Employees | 4 | 3 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Beldean Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.806 | 2.935 | 35.577 | 45.699 | 41.125 | 124.879 | 160.059 | 222.817 | 249.245 | 256.597 |
| Current Assets | 2.925 | 24.001 | 40.315 | 38.043 | 93.696 | 148.372 | 178.442 | 193.320 | 244.162 | 268.179 |
| Inventories | 16 | 16 | 3.748 | 21 | 9.863 | 19.880 | 26.777 | 33.355 | 26.397 | 20.628 |
| Receivables | 2.273 | 2.035 | 870 | 5.499 | 11.161 | 31.263 | 27.578 | 30.217 | 40.585 | 33.551 |
| Cash | 636 | 21.951 | 35.697 | 32.523 | 72.671 | 97.229 | 124.087 | 129.748 | 177.179 | 214.000 |
| Shareholders Funds | -2.507 | 17.571 | 71.268 | 59.549 | 77.376 | 208.885 | 248.546 | 192.307 | 313.025 | 352.376 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.674 | 9.775 | 4.624 | 24.254 | 59.905 | 65.033 | 90.608 | 224.485 | 181.035 | 173.049 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Beldean Med S.r.l.